KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Cost of Revenue (2016 - 2025)

Thermo Fisher Scientific's Cost of Revenue history spans 17 years, with the latest figure at $3.7 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 14.91% year-over-year to $3.7 billion, compared with a TTM value of $13.3 billion through Dec 2025, up 6.77%, and an annual FY2025 reading of $13.4 billion, up 5.93% over the prior year.
  • Cost of Revenue for Q4 2025 was $3.7 billion at Thermo Fisher Scientific, up from $3.2 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $3.7 billion in Q4 2023, with the low at -$4.0 billion in Q4 2021.
  • Average Cost of Revenue over 5 years is $2.6 billion, with a median of $3.2 billion recorded in 2024.
  • Year-over-year, Cost of Revenue crashed 97.22% in 2021 and then skyrocketed 10487.88% in 2022.
  • Tracing TMO's Cost of Revenue over 5 years: stood at -$4.0 billion in 2021, then skyrocketed by 128.31% to $1.1 billion in 2022, then surged by 229.77% to $3.7 billion in 2023, then decreased by 13.23% to $3.2 billion in 2024, then grew by 14.91% to $3.7 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Cost of Revenue are $3.7 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.2 billion (Q2 2025).